Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Assets    
Financing receivables $ 1,042,237 $ 783,967
Financing receivables held-for-sale   60,376
Investments available-for-sale 58,058 29,017
Real estate 172,257 155,699
Equity method investments 363,297 318,769
Cash and cash equivalents 29,428 42,645
Other assets 80,610 79,148
Total Assets 1,745,887 1,469,621
Liabilities:    
Accounts payable, accrued expenses and other 25,219 17,875
Deferred funding obligations 170,892 108,499
Credit facility 283,346 247,350
Nonrecourse debt (secured by assets of $864 million and $815 million, respectively) 692,091 663,791
Total Liabilities 1,171,548 1,037,515
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 46,493,155 and 37,010,603 shares issued and outstanding, respectively 465 370
Additional paid in capital 663,744 482,431
Retained deficit (92,213) (52,701)
Accumulated other comprehensive income (loss) (1,388) (1,905)
Non-controlling interest 3,731 3,911
Total Stockholders' Equity 574,339 432,106
Total Liabilities and Stockholders' Equity $ 1,745,887 $ 1,469,621